Category Archives: News

SOM Biotech is one of the Top Spanish Start-ups to follow in 2020

SOM Biotech is one of the Top Spanish Start-ups to follow in 2020 according to Sifted. Since its foundation in 2009, SOM Biotech stands out for its dynamism, its scientific rigor, and its innovative spirit. As an AI drug discovery company, SOM Biotech has developed more than 50 projects, has licensed 2 products and has obtained …

SOM Biotech achieves relevant advances in its pipeline leveraging on its proprietary AI based drug discovery technology SOM[AI]- PRO

SOM Biotech closes a remarkable year, achieving relevant advances in its drug development pipeline. Leveraging on its proprietary AI-based drug discovery technology SOMAI-PRO. According to Raul Insa – CEO of SOM Biotech – “ 2019 has been a great year, in which we have achieved major milestones in our pipeline development. Those achievements prove that …

SOM Biotech at the Invest Securities Biomed Event

SOM Biotech attends the Invest Securities Biomed Event on January 28th in Paris. Raul Insa – CEO of SOM Biotech – participates in “one to one” meetings with international institutional investors. Therefore, according to Dr. Insa: “we will have the opportunity to share with qualified investors SOM´s future strategic growth plan. Certainly, we understand, that …

Biomedical companies rise 60 million in investment rounds – Press release EXPANSIÓN Catalunya

The Catalan Biotechnology and digital health companies dedicated to biomedicine and digital health captured 59.8 million euros in 2019 in financing rounds, 4.9% more than in 2018, when the investment volume reached 57 million, according to the ranking elaborated by EXPANSIÓN Catalunya. SOM Biotech is in third place on the list of those companies. In …

SOM Biotech at the JP Morgan Healthcare Conference and Biotech Showcase 2020

SOM Biotech will attend the JP Morgan Healthcare Conference and Biotech Showcase Conference on January 13rd -15th 2020 – in San Francisco, USA. Raul Insa – CEO and Maria Zimina – Business Development Manager of SOM Biotech – will be attending one-to-one meetings with qualified life science investors as well as other biotech and pharma …

SOM Biotech attended the FDA Workshop

SOM Biotech at the FDA Workshop

SOM Biotech attended the FDA Workshop “Repurposing Off-Patent Drugs: Research & Regulatory Challenge” on December 5th -6th– in Rockville, USA. The workshop aimed at exploring opportunities and challenges in assessing the safety and efficacy of repurposed drugs, as well as exploring several drug development pathways for treatments, with a specific focus on orphan diseases. Núria …

SOM Biotech at the 10th Drug Discovery Innovation Programme

SOM Biotech participated in the 10th Drug Discovery Innovation Programme that took place on November 28th -29th- in Barcelona, Spain. Luca Signorile – Computational Chemist of SOM Biotech –performed the presentation on the topic “Re-Discovering Drugs: Advantages, Perspectives, and the role of AI.” During his speech, he gave an insight into the computational side of …

SOM Biotech at the Clinical Trials Europe 2019 conference

SOM Biotech has participated in the “Clinical Trials Europe 2019” conference, that took place on November 19th -21st- in Barcelona, Spain. The “Clinical Trials Europe 2019”, one of the leading platforms to build partnerships to develop clinical trials, attracts a wide range of innovative research centers and business development teams from biotech and pharma companies. …

SOM Biotech at the 10th World Orphan Drug Congress 2019

SOM Biotech participated in the World Orphan Drug Congress Europe 2019 on November 12th -14th– in Barcelona, Spain, where the company was a Showcase Sponsor. Raul Insa – CEO of SOM Biotech – presented “Case study: Systematic drug re-innovation and clinical evidence in orphan diseases”. SOM Biotech shared its latest findings in drug discovery and …

SOM Biotech at European Conference on Recent Advances in Lysosomal Diseases

Gal·la Pericot, R&D Manager at SOM Biotech, attended the European Conference on Recent Advances in Lysosomal Diseases, which took place on 24-25 October 2019 in London, UK. The main objective of the conference was sharing of innovative knowledge on the development of new therapeutic modalities for treating disorders linked to the lysosomal storage in the cells, …